ArticleHeliyon2024
Synergistic anticancer effects of SMYD2 inhibitor BAY-598 and doxorubicin in non-small cell lung cancer.
Jiaqi Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleHeliyon2024
Jiaqi Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.